The pharmaceutical services provider Sterling Pharma Solutions will produce hypericin, the active ingredient in an oncology drug being developed by the biotech firm Soligenix. Sterling says it will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback